XBiotech (XBIT) Tax Provisions (2019 - 2026)
XBiotech (XBIT) posted quarterly Tax Provisions of $76000.0 for Q4 2025, up 285.37% year-over-year from $19721.5 in Q4 2024, and down 25.49% quarter-over-quarter from $102000.0 in Q3 2025.
XBiotech (XBIT) Tax Provisions (2019 - 2026) Analysis & Trends
XBiotech's Tax Provisions history runs 7 years deep, the most recent figure standing at $76000.0 for Q4 2025.
- In Q4 2025, Tax Provisions rose 285.37% year-over-year to $76000.0; the TTM figure through Dec 2025 stood at $235000.0 (up 834.38% YoY), while the FY2025 annual figure was $235000.0, up 834.38% from the prior year.
- Tax Provisions for Q4 2025 stood at $76000.0, down from $102000.0 in the prior quarter.
- The five-year high for Tax Provisions was $2.4 million in Q3 2022, with the low at -$4.6 million in Q2 2021.
- The 5-year median for Tax Provisions is $17000.0 (2024), against an average of -$478250.0.
- The sharpest annual moves came in 2021 and 2025: Tax Provisions tumbled 1277.41% in 2021, then jumped 1033.33% in 2025.
- XBiotech's Tax Provisions stood at -$2.6 million in 2021, then surged by 122.13% to $578000.0 in 2022, then plunged by 106.92% to -$40000.0 in 2023, then retreated by 2.5% to -$41000.0 in 2024, then surged by 285.37% to $76000.0 in 2025.
- Business Quant data shows XBIT's Tax Provisions at $76000.0 in Q4 2025, $102000.0 in Q3 2025, and $28000.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 292.00 Mn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 230.90 Mn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 59.00 Mn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 15.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 75.45 Mn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 13.31 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 1.90 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | -90.33 Mn |
| 10 | XBiotech | 68.90 Mn | 68.90 Mn | - | 46,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 46,000.00 |
| Dec 31, 2025 | 76,000.00 |
| Sep 30, 2025 | 102,000.00 |
| Jun 30, 2025 | 28,000.00 |
| Mar 31, 2025 | 29,000.00 |
| Dec 31, 2024 | -41,000.00 |
| Sep 30, 2024 | 9,000.00 |
| Jun 30, 2024 | -25,000.00 |
| Mar 31, 2024 | 25,000.00 |
| Dec 31, 2023 | -40,000.00 |
| Sep 30, 2023 | 308,000.00 |
| Jun 30, 2023 | 71,000.00 |
| Mar 31, 2023 | 37,000.00 |
| Dec 31, 2022 | 578,000.00 |
| Sep 30, 2022 | 2.40 Mn |
| Jun 30, 2022 | -2.61 Mn |
| Mar 31, 2022 | -1.06 Mn |
| Dec 31, 2021 | -2.61 Mn |
| Sep 30, 2021 | -1.79 Mn |
| Jun 30, 2021 | -4.57 Mn |